Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique

Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Azria, D., Hennequin, C., Giraud, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. 2020
Materias:
Mise Au Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146696/
https://www.ncbi.nlm.nih.gov/pubmed/32307313
http://dx.doi.org/10.1016/j.canrad.2020.04.001
_version_ 1783520261056757760
author Azria, D.
Hennequin, C.
Giraud, P.
author_facet Azria, D.
Hennequin, C.
Giraud, P.
author_sort Azria, D.
collection PubMed
description Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to compensate the total dose in case of temporary treatment interruption are well known but it is of importance in that pandemic context to update and homogenize clinical practice in order to improve local control without increasing normal tissue complications.
format Online
Article
Text
id pubmed-7146696
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71466962020-04-10 Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique Azria, D. Hennequin, C. Giraud, P. Cancer Radiother Mise Au Point Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to compensate the total dose in case of temporary treatment interruption are well known but it is of importance in that pandemic context to update and homogenize clinical practice in order to improve local control without increasing normal tissue complications. Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. 2020-06 2020-04-10 /pmc/articles/PMC7146696/ /pubmed/32307313 http://dx.doi.org/10.1016/j.canrad.2020.04.001 Text en © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Mise Au Point
Azria, D.
Hennequin, C.
Giraud, P.
Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique
title Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique
title_full Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique
title_fullStr Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique
title_full_unstemmed Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique
title_short Compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de COVID-19 : mise au point pratique
title_sort compensation de la dose totale en cas d’interruption temporaire de radiothérapie externe dans le contexte de la pandémie de covid-19 : mise au point pratique
topic Mise Au Point
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146696/
https://www.ncbi.nlm.nih.gov/pubmed/32307313
http://dx.doi.org/10.1016/j.canrad.2020.04.001
work_keys_str_mv AT azriad compensationdeladosetotaleencasdinterruptiontemporairederadiotherapieexternedanslecontextedelapandemiedecovid19miseaupointpratique
AT hennequinc compensationdeladosetotaleencasdinterruptiontemporairederadiotherapieexternedanslecontextedelapandemiedecovid19miseaupointpratique
AT giraudp compensationdeladosetotaleencasdinterruptiontemporairederadiotherapieexternedanslecontextedelapandemiedecovid19miseaupointpratique

Ejemplares similares